United States · Series C startup

Who invested in Antiva

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2018, from 1 source

Latest round
Series C, $15MJul 2018
Investors
6
See who backed them

The rounds

  1. Jul 2018
    Series C$15M

    Reported by FinSMEs

Everyone who backed them

CanaanVC firm1round
Lumira VenturesVC firm1round
Brace PharmaCompany1round
Hillhouse Capital Management/ Sironano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Antiva

Who invested in Antiva?

Antiva's investors include Canaan, Sofinnova Investments, Osage University Partners, Lumira Ventures and Brace Pharma, and 1 more on record.

How much has Antiva raised?

Antiva has raised $15M across 1 round since 2018.

When did Antiva last raise?

Antiva's most recent round was a Series C of $15M in Jul 2018.

What was Antiva's biggest round?

Its most recent round, $15M in Jul 2018, is also its largest on record.

Who backed Antiva first?

Antiva's first round on record, in Jul 2018, was backed by Canaan, Sofinnova Investments and Osage University Partners and 3 others.

What stage is Antiva at?

Antiva's latest named round is a Series C, in Jul 2018.

Where is Antiva based?

Antiva is based in the United States.

Companies like Antiva

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.